Eagle Bay Advisors LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 178 filers reported holding ALLOGENE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.

Quarter-by-quarter ownership
Eagle Bay Advisors LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$685
-36.2%
2160.0%0.00%
-100.0%
Q2 2023$1,074
+101.1%
216
+100.0%
0.00%
Q1 2023$534
-21.4%
1080.0%0.00%
Q4 2022$679
-32.1%
1080.0%0.00%
-100.0%
Q3 2022$1,000
-99.9%
1080.0%0.00%0.0%
Q2 2022$1,231,000
+61450.0%
1080.0%0.00%0.0%
Q4 2021$2,000
-33.3%
1080.0%0.00%
-50.0%
Q3 2021$3,0000.0%1080.0%0.00%0.0%
Q2 2021$3,0001080.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders